More
A new study, led by the International Agency for Research on Cancer (IARC), examined the potential of epigenetic (DNA methylation) changes in pre-diagnostic blood samples as a marker of exposure to tobacco smoke in a large multinational cohort (EPIC). The study comprehensively catalogued the smoking-associated alterations in the epigenome and showed that these alterations are reversible, underscoring the benefits of smoking cessation.
Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study
Ambatipudi A, Cuenin C, Hernandez-Vargas H, Ghantous A, Le Calvez-Kelm F, Kaaks R, et al.
Epigenomics, Published online 11 February 2016.
Scientists from the International Agency for Research on Cancer (IARC) and partner institutions h...
The monograph on aspartame, the first monograph in IARC Monographs Volume 134: Aspartame, Methyle...
The International Agency for Research on Cancer (IARC) is pleased to announce the launch of the C...